No photo of Jessica K Altman

View Scopus Profile

Jessica K Altman

  • 4702 Citations
20052024

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Certifications and Licenses

Medical Oncology
Hematology
Internal Medicine

Training Experience

2004Residency, University of Chicago Hospitals
2007Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, University of Pittsburgh

… → 2001

Research interests

  • Acute Leukemias
  • Anemia
  • Aplastic Anemia
  • Chronic Leukemias
  • Leukemia
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Targeted Therapies

Fingerprint Dive into the research topics where Jessica K Altman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Prot #KRT-232-104: An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined with Low-Dose Cytarabine (LDAC) or Decitabine in Patients with Acute Myeloid Leukemia (AML)

Altman, J. K.

INC Research, LLC, Kartos Therapeutics, Inc.

2/5/20 → 2/5/23

Project: Research project

Prot #PrE0905: Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML)

Altman, J. K.

Alpha Oncology, Inc., PrECOG, LLC

1/30/20 → 1/30/23

Project: Research project

Prot #A19-11184: Phase I Study of APR-246 in Combination with Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies

Altman, J. K.

Theradex, Aprea Therapeutics AB

1/21/20 → 1/21/23

Project: Research project

Prot #KO-MEN-001: A Phase 1 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Altman, J. K.

Pharm-Olam International Ltd., Kura Oncology, Inc.

1/15/20 → 1/15/23

Project: Research project

Prot #A18-15331: A Phase III Multicenter, Randomized, Open Label Study of APR-246 in Combination with Azacitidine Versus Azacitidine Alone for the Treatment of TP53 Mutant Myelodysplastic Syndromes

Altman, J. K.

Theradex, Aprea Therapeutics AB

9/26/19 → 9/26/22

Project: Research project

Research Output

Unique morphologic and genetic characteristics of acute myeloid leukemia with chromothripsis: a clinicopathologic study from a single institution

Gao, J., Chen, Y. H., Mina, A., Altman, J. K., Kim, K. Y., Zhang, Y., Lu, X., Jennings, L. & Sukhanova, M., Apr 2020, In : Human pathology. 98, p. 22-31 10 p.

Research output: Contribution to journal › Article

    • Acute myeloid leukemia, version 3.2019

    Tallman, M. S., Wang, E. S., Altman, J. K., Appelbaum, F. R., Bhatt, V. R., Bixby, D., Coutre, S. E., De Lima, M., Fathi, A. T., Fiorella, M., Foran, J. M., Hall, A. C., Jacoby, M., Lancet, J., LeBlanc, T. W., Mannis, G., Marcucci, G., Martin, M. G., Mims, A., O'Donnell, M. R. & 14 others, Olin, R., Peker, D., Perl, A., Pollyea, D. A., Pratz, K., Prebet, T., Ravandi, F., Shami, P. J., Stone, R. M., Strickland, S. A., Wieduwilt, M., Gregory, K. M., Hammond, L. & Ogba, N., Jan 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 6, p. 721-749 29 p.

    Research output: Contribution to journal › Article

    • 24 Scopus citations

    An integrative approach reveals genetic complexity and epigenetic perturbation in acute promyelocytic leukemia: a single institution experience

    Rahimi, N., Zhang, Y., Mina, A., Altman, J. K., Sukhanova, M., Frankfurt, O., Jennings, L., Lu, X., Behdad, A., Chen, Q., Chen, Y. H. & Gao, J., Sep 2019, In : Human pathology. 91, p. 1-10 10 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease

    Litzow, M. R., Wang, X. V., Carroll, M. P., Karp, J. E., Ketterling, R. P., Zhang, Y., Kaufmann, S. H., Lazarus, H. M., Luger, S. M., Paietta, E. M., Pratz, K. W., Tun, H. W., Altman, J. K., Broun, E. R., Rybka, W. B., Rowe, J. M. & Tallman, M. S., Jan 2019, In : American Journal of Hematology. 94, 1, p. 111-117 7 p.

    Research output: Contribution to journal › Article

    • 3 Scopus citations

    Aurora kinase A inhibition provides clinical benefit, normalizes megakaryocytes, and reduces bone marrow fibrosis in patients with myelofibrosis: A phase I trial

    Gangat, N., Marinaccio, C., Swords, R., Watts, J. M., Gurbuxani, S., Rademaker, A., Fought, A. J., Frankfurt, O., Altman, J. K., Wen, Q. J., Farnoud, N., Famulare, C. A., Patel, A., Tapia, R., Vallapureddy, R. R., Barath, S., Graf, A., Handlogten, A., Zblewski, D., Patnaik, M. M. & 14 others, Al-Kali, A., Dinh, Y. T., Prahl, K. E., Patel, S., Nobrega, J. C., Tejera, D., Thomassen, A., Gao, J., Ji, P., Rampal, R. K., Giles, F. J., Tefferi, A., Stein, B. & Crispino, J. D., Aug 15 2019, In : Clinical Cancer Research. 25, 16, p. 4898-4906 9 p.

    Research output: Contribution to journal › Article

    • 10 Scopus citations